Renee Pride, MD
MOHS-Micrographic Surgery · Denver, CONPI 1639609480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $633 and has fallen 82.6% since, to $110 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in CO, where the typical reported total is $1,865.
Across 80 payments — averaging $23.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$359
- Amgen$283
- Sun Pharmaceutical Industries Inc.$160
- Regeneron Healthcare Solutions, Inc.$156
- Pfizer$156
- AbbVie$142
- plus $609 from 10 others
What the payments were for
- Food & beverage$1,85099%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $359 |
| Amgen | 10 | $283 |
| Sun Pharmaceutical Industries Inc. | 8 | $160 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| Pfizer | 6 | $156 |
| AbbVie | 6 | $142 |
| Galderma Laboratories, L.p. | 2 | $119 |
| Incyte Corporation | 5 | $114 |
| Lilly USA, LLC | 4 | $103 |
| Sanofi | 3 | $68 |
| Biofrontera Inc. | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Dermavant Sciences, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $18 |
How this compares
$1,865 in reported general payments places this provider in the 50th percentile of 37 mohs-micrographic surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 42 | $588 |
| Triamcinolone Acetonide | 46 | $501 |
| Mupirocin | 27 | $147 |
| Hydrocortisone | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Denver
- Misha MillerDenver$5K
- Milton SchleveDenver$3K
- Karen SundbyDenver$69
- Joel CohenGreenwood Village$426K
- Shawn AllenBoulder$69K
- Kevin MottLoveland$33K
- Karen NernEdwards$28K
- Vinh ChungColorado Springs$10K
- Brett MathesonColorado Spgs$10K
- Joseph WildeFort Collins$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.